Bipolar mood disorder in pregnancy

Bipolar mood disorder is a chronic psychiatric disorder characterized by recurrent episodes of mania, hypomania, depression, or mixed affective states. The disorder is associated with significant impairment in social, occupational, and psychological functioning and may substantially affect maternal and fetal well-being during pregnancy.

Pregnancy does not protect against bipolar disorder relapse. Women with pre-existing bipolar disorder remain at risk of experiencing mood episodes during pregnancy, particularly if mood stabilizing medications are discontinued. Untreated bipolar disorder during pregnancy may result in poor self-care, impaired antenatal care attendance, substance misuse, suicidal behavior, and adverse pregnancy outcomes.

Management requires careful balancing of the risks associated with untreated maternal illness against the potential risks of pharmacological treatment to the developing fetus.

Epidemiology

Bipolar mood disorder commonly affects women of reproductive age. Women with established bipolar disorder may experience relapse during pregnancy, particularly following discontinuation of mood stabilizers.

The risk of relapse is influenced by the severity of previous illness, treatment adherence, psychosocial stressors, and availability of social support.

Risk Factors

Clinical risk factors

• Previous diagnosis of bipolar mood disorder

• Previous manic, hypomanic, or depressive episodes

• Discontinuation of mood stabilizing medication

• Previous psychiatric hospitalization

• Family history of bipolar disorder

• Coexisting psychiatric disorders

• Substance use disorders

Psychosocial risk factors

• Stressful life events

• Poor social support

• Marital or relationship difficulties

• Financial difficulties

• Sleep deprivation

• Lack of family support

Pathophysiology

The exact cause of bipolar mood disorder is not fully understood. The disorder is believed to result from a complex interaction of genetic, neurobiological, and environmental factors.

Potential mechanisms include:

• Dysregulation of serotonin, dopamine, and norepinephrine neurotransmission

• Abnormalities within limbic and prefrontal brain circuits

• Genetic susceptibility

• Neuroendocrine dysfunction

• Circadian rhythm disturbances

Hormonal and psychosocial changes associated with pregnancy may influence symptom expression and increase vulnerability to relapse.

Clinical presentation

Clinical manifestations vary depending on whether the patient is experiencing mania, hypomania, depression, or a mixed episode.

Symptoms of mania

• Elevated or euphoric mood

• Excessive energy

• Reduced need for sleep

• Increased talkativeness

• Racing thoughts

• Increased self-confidence or grandiosity

• Distractibility

• Increased goal-directed activity

• Impulsive behavior

• Risk-taking activities

Symptoms of hypomania

• Persistently elevated or irritable mood

• Increased activity levels

• Increased productivity

• Reduced need for sleep

• Increased sociability

• Increased self-confidence

Symptoms of bipolar depression

• Persistent sadness

• Loss of interest in activities

• Fatigue

• Poor concentration

• Feelings of hopelessness

• Sleep disturbances

• Appetite changes

• Suicidal thoughts

Clinical signs

• Mood instability

• Psychomotor agitation or retardation

• Pressured speech

• Grandiosity

• Impaired judgment

• Distractibility

• Reduced insight

• Functional impairment

DSM-5 Classification

According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), bipolar disorders include:

Bipolar I disorder

Characterized by at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes.

Bipolar II disorder

Characterized by at least one hypomanic episode and at least one major depressive episode, without a history of a full manic episode.

Cyclothymic disorder

Characterized by numerous periods of hypomanic symptoms and depressive symptoms that do not meet the full criteria for hypomanic or major depressive episodes.

Other specified and unspecified bipolar and related disorders

Used when symptoms cause clinically significant impairment but do not fully meet criteria for the above categories.

Differential Diagnosis

Psychiatric conditions

• Major depressive disorder

• Generalized anxiety disorder

• Panic disorder

• Schizoaffective disorder

• Schizophrenia

• Adjustment disorder

• Substance-induced mood disorder

• Personality disorders

Medical conditions

• Hyperthyroidism

• Hypothyroidism

• Neurological disorders

• Systemic lupus erythematosus

• Medication-induced mood changes

Pregnancy-related conditions

• Normal emotional changes of pregnancy

• Sleep deprivation associated with pregnancy

• Anxiety related to pregnancy and childbirth

Diagnostic Criteria

Diagnosis is based on:

• Presence of manic, hypomanic, depressive, or mixed episodes

• Assessment of symptom duration and severity

• Functional impairment

• Exclusion of substance-induced conditions

• Exclusion of medical causes of mood symptoms

• Comprehensive psychiatric evaluation

Investigations

Laboratory investigations

• Full blood count

• Blood glucose assessment

• Thyroid function tests

• Liver function tests

• Renal function tests

• Electrolytes where indicated

Mental health assessment

• Comprehensive psychiatric evaluation

• Assessment of mood symptoms

• Suicide risk assessment

• Assessment of psychosocial stressors

• Evaluation of family support systems

Additional investigations

• Drug level monitoring where indicated

• Additional investigations guided by clinical findings

Management

Management should be individualized according to the severity of illness, previous treatment response, gestational age, risk of relapse, and patient preference.

The goals of treatment are to:

• Maintain mood stability

• Prevent relapse

• Promote maternal functioning

• Minimize fetal risk

• Improve pregnancy outcomes

Non-pharmacological treatment

Non-pharmacological interventions should be offered to all patients.

Cognitive behavioral therapy

• Improves coping strategies

• Enhances treatment adherence

• Assists in recognizing early warning signs of relapse

Supportive psychotherapy

• Provides emotional support

• Addresses pregnancy-related concerns

• Improves psychosocial functioning

Relaxation techniques

• Deep breathing exercises

• Progressive muscle relaxation

• Stress management strategies

• Mindfulness-based interventions

Sleep hygiene

• Maintenance of regular sleep patterns

• Management of insomnia

• Avoidance of sleep deprivation

Dietary counseling

• Balanced nutrition

• Healthy lifestyle practices

• Limitation of substances that may worsen mood instability

Pharmacological treatment

Pharmacological treatment should follow the specific management protocols for bipolar mood disorder and mood episodes previously outlined in the relevant treatment sections.

The decision to initiate, continue, discontinue, or modify mood stabilizing medication during pregnancy should be made following a comprehensive assessment of risks and benefits.

Principles of pharmacological treatment

• Decision whether to use mood stabilizers must be made following an assessment of risks and benefits.

• Low doses of mood stabilizers should be used whenever clinically appropriate.

• Factors to consider include the number and severity of previous episodes, level of insight, family support, and the wishes of the woman.

• Careful monitoring of psychological symptoms throughout pregnancy is of paramount importance.

• Abrupt discontinuation of mood stabilizers should be avoided unless clinically indicated.

• Treatment decisions should involve shared decision-making between the patient and healthcare providers.

Management according to clinical presentation

Bipolar depression

• Optimize psychiatric follow-up

• Implement psychological interventions

• Consider pharmacological treatment according to established bipolar disorder treatment protocols

• Monitor closely for suicidal ideation

Mania or hypomania

• Assess severity and risk

• Optimize mood stabilizing treatment according to established treatment protocols

• Ensure patient safety

• Monitor adherence and treatment response

Mixed affective episodes

• Urgent psychiatric assessment

• Close monitoring

• Individualized treatment plan

• Consider hospitalization when clinically indicated

Referral

Refer the patient when:

• Diagnosis is uncertain

• Mania, hypomania, or severe depression is present

• Psychotic symptoms occur

• Suicidal ideation or behavior is present

• There is significant functional impairment

• Specialized perinatal mental health services are required

• Hospital admission is necessary

Complications

Maternal complications

• Relapse of bipolar disorder

• Poor antenatal care attendance

• Self-harm

• Suicide

• Substance misuse

• Relationship difficulties

• Occupational impairment

Fetal and neonatal complications

• Poor fetal outcomes associated with severe untreated maternal illness

• Effects related to poor maternal self-care

• Potential medication-related complications depending on treatment used

Prognosis

The prognosis depends on illness severity, treatment adherence, availability of social support, and continuity of psychiatric care. Women who receive comprehensive antenatal, psychiatric, and family support generally experience better outcomes.

Close monitoring throughout pregnancy and the postpartum period is essential because the risk of relapse remains significant.

Prevention

• Early identification of women at risk

• Preconception counseling for women with known bipolar disorder

• Regular psychiatric follow-up

• Maintenance of treatment adherence

• Stress reduction strategies

• Strong family and social support

• Early intervention when symptoms emerge

Special Considerations

• Pregnancy does not eliminate the risk of bipolar relapse.

• Women with a history of severe bipolar disorder require close psychiatric monitoring throughout pregnancy.

• Decisions regarding mood stabilizer use should be individualized after careful assessment of risks and benefits.

• The lowest effective dose should be used whenever pharmacological treatment is required.

• Factors influencing treatment decisions include the number and severity of previous episodes, level of insight, family support, and the wishes of the woman.

• Careful monitoring of psychological symptoms throughout pregnancy is essential.